FirstCry Q1: consolidated loss narrows 34% YoY to ₹44 Cr; core India EBITDA falls 22%

Brainbees Solutions (FirstCry) reported consolidated revenue of ₹2,106.23 Cr for Q1 FY27, up 13.1% YoY (down 2.6% QoQ — Q4 is the seasonally stronger quarter for baby/kids retail, so the sequential dip is not a red flag). The consolidated net loss narrowed to ₹43.95 Cr from ₹66.50 Cr a year ago (-33.9% YoY) and from ₹48.21 Cr in Q4FY26 (-8.8% QoQ), with NPM improving to -2.09% from -3.48% YoY. The quarter carried a larger one-off drag than a year ago — an ₹18.40 Cr exceptional charge (mostly a ₹18.34 Cr inventory write-off at GlobalBees step-down subsidiaries) versus ₹6.46 Cr in Q1FY26 — so on an adjusted (ex-exceptional) basis the underlying loss narrowed a much sharper ~57% YoY, to ₹25.55 Cr from ₹60.05 Cr.

The margin bridge is not where the headline suggests. India multi-channel, the largest segment (69% of revenue), grew revenue 17.7% YoY to ₹1,455.91 Cr, but its segment EBITDA (before D&A) fell 21.7% YoY to ₹83.48 Cr and segment result (post-D&A) fell 57.2% YoY to ₹17.11 Cr — a clear compression in the core business, directly contradicting management's FY27 guidance (from the Q4FY26 call) of "double-digit EBITDA growth for the India multi-channel business." That guidance has been missed in the opening quarter of the year. What actually pulled the group loss down was below-the-line: ESOP expense fell 50.3% YoY to ₹29.62 Cr, D&A fell 6.7% to ₹94.34 Cr, and finance costs fell 9.2% to ₹36.58 Cr. GlobalBees' loss narrowed sharply to ₹3.72 Cr from ₹20.82 Cr YoY, and the International segment's loss narrowed to ₹22.94 Cr from ₹26.28 Cr, both improving the total segment result to a ₹5.06 Cr loss from ₹8.33 Cr YoY.

The stock went into the print at ₹214.14, up 0.7% over the past month of trading.

For context: this is the second-highest quarterly PAT of the last 6 quarters.

No Q1FY27-specific Street consensus for revenue or PAT could be located; Trendlyne's aggregated FY27 full-year analyst forecast points to ~14.6% revenue growth and ~153.8% profit growth for the year, a trajectory this quarter's 13.1% revenue growth and narrowing loss is broadly consistent with, though a single quarter cannot confirm the full-year call. Management's Q4FY26 outlook also flagged gross-margin recovery starting Q2FY27 — not yet testable in this print. Standalone entity profit (₹21.59 Cr PAT, up from ₹3.07 Cr YoY) stands in contrast to the consolidated loss; the gap is structural, reflecting that International and GlobalBees losses sit in subsidiaries consolidated only at the group level. Corporately, the quarter also saw step-down subsidiary Swara Baby Products file a DRHP for a ₹1,000 Cr IPO (Brainbees plans to sell ₹300 Cr of shares in it) and the Brainbees ESOP Trust receive an income-tax notice for AY2022-23 — neither has a P&L impact yet, but both are relevant to the group's capital structure this fiscal year.